Previous close | 1.4500 |
Open | 1.3000 |
Bid | 1.2500 |
Ask | 1.4500 |
Strike | 17.50 |
Expiry date | 2024-01-19 |
Day's range | 1.3000 - 1.3300 |
Contract range | N/A |
Volume | |
Open interest | 31 |
The iconic money manager has struggled the last two months. Let's see what she's buying to get back on track.
Despite a sizzling start to the year, growth stocks have suddenly found themselves on the outs with investors. Concerns about the global economy, persistently high interest rates, and stubborn levels of inflation have weighed heavily on pure-play growth stocks in the second half of the year. Biotechnology stocks have taken a particularly hard hit over this period.
Warren Buffett has been a net seller of stocks in recent months, but it's a different story for Cathie Wood. If you're an aggressive investor, here are three stocks that Wood is buying that should be on your list, too. Wood's flagship Ark Innovation ETF added to its existing position in Beam Therapeutics (NASDAQ: BEAM) over the last several weeks.